CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)
Price and Volume
Detailed Quote| Volume | 1,840 |
| Open | 3.980 |
| Bid (Size) | 3.910 (500) |
| Ask (Size) | 4.250 (100) |
| Prev. Close | 3.940 |
| Today's Range | 3.770 - 3.980 |
| 52wk Range | 1.900 - 10.54 |
| Shares Outstanding | 1,461,449 |
| Dividend Yield | N/A |
Top News
More NewsPerformance
52-Week Range
64.2% below 52-week high
3.770
1.9052W Low
10.5452W High
1 Week
19.8% below 1-week high
3.891W Low
4.701W High
CNS Pharmaceuticals, Inc. - Common Stock (CNSP) traded between $1.90 and $10.54 over the past 52 weeks and last traded at $3.77, 64.2% below its 52-week high. Over the past week it ranged between $3.89 and $4.70.
Past 12 Months
1W
-$0.78
1M
-$1.42
3M
-$1.36
6M
-$2.99
YTD
-$1.53
1Y
-$2.72
CNSP was -41.9% over the past year, -44.2% over six months, -28.9% year to date, -17.1% in the last week.
12 Months vs Market
CNSP
-41.9%
DIA
+9.8%
SPY
+9.5%
QQQ
+7.3%
IWM
+14.6%
Over the past 12 months CNSP returned -41.9% versus DIA (Dow) +9.8%, SPY (S&P 500) +9.5%, QQQ (Nasdaq 100) +7.3% and IWM (Russell 2000) +14.6%.
Volume & Liquidity
0.20× 3-mo avg
Today 1,840
3-mo avg 9.4K
1W
7.1K
1M
17.2K
3M
9.4K
6M
23.6K
YTD
433.4K
1Y
373.3K
CNSP most recently traded 1,840 shares against a 3-month average daily volume of 9.4K.
More News
Read More
New Vaccine Shows Potential to Extend Lives of Brain Cancer Patients
October 19, 2026
The Skull Could Be Playing an Immune System Role for the Brain
October 06, 2026
NHS England Unveils Rapid Test for Brain Tumors
October 05, 2026
New T Cell Therapy Could Transform Glioblastoma Care
August 24, 2026
Injectable Nanodevices Exhibit Potency Against Brain Tumors
September 21, 2026
Laser Therapy Shows Promise in Treating Brain Cancer
September 08, 2026
Timing of Brain Metastasis Predicts Survival of Colorectal Cancer Patients
September 04, 2026
Covid-19 Vaccine Could Extend Survival of Brain Cancer Patients
August 27, 2026
Focused Ultrasound Shows Promise in Treating Brain Tumors
August 10, 2026
Spanish Patient Highlights Risks of Poorly Cooked Pork
August 07, 2026
Frequently Asked Questions
Is CNS Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, CNS Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does CNS Pharmaceuticals, Inc. - Common Stock trade on?
CNS Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for CNS Pharmaceuticals, Inc. - Common Stock is CNSP on the Nasdaq Stock Market
What is the current price of CNS Pharmaceuticals, Inc. - Common Stock?
The current price of CNS Pharmaceuticals, Inc. - Common Stock is 3.770
When was CNS Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of CNS Pharmaceuticals, Inc. - Common Stock was at 11/10/26 11:14 AM ET
What is the market capitalization of CNS Pharmaceuticals, Inc. - Common Stock?
The market capitalization of CNS Pharmaceuticals, Inc. - Common Stock is 5.51M
How many shares of CNS Pharmaceuticals, Inc. - Common Stock are outstanding?
CNS Pharmaceuticals, Inc. - Common Stock has 6M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.